Fordyce Marshall: insider trades.
Fordyce Marshall reported 19 non-derivative transactions on 6 SEC ownership filings in Q3 2026: 0 open-market purchases and 14 sales ($6.6M), across 1 company.
- Transactions
- 19
- Purchases (P)
- 0
- Sales (S)
- 14
- Companies
- 1
- Name as filed
- Fordyce Marshall
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Vera Therapeutics, Inc. (VERA) | Director, Officer · PRESIDENT AND CEO | 19 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-15 | Vera Therapeutics, Inc. | S | 18,500 | $37 | 235,244 | Form 4 |
| 2026-09-15 | Vera Therapeutics, Inc. | M | 18,500 | $2.9 | 253,744 | Form 4 |
| 2026-09-02 | Vera Therapeutics, Inc. | M | 18,500 | $2.9 | 253,744 | Form 4 |
| 2026-09-02 | Vera Therapeutics, Inc. | S | 18,500 | $35.12 | 235,244 | Form 4 |
| 2026-07-07 | Vera Therapeutics, Inc. | M | 46,250 | $2.9 | 281,494 | Form 4/A |
| 2026-07-07 | Vera Therapeutics, Inc. | S | 1,000 | $40.78 | 280,494 | Form 4/A |
| 2026-07-07 | Vera Therapeutics, Inc. | S | 2,200 | $43.59 | 235,244 | Form 4/A |
| 2026-07-07 | Vera Therapeutics, Inc. | S | 10,500 | $42.86 | 237,444 | Form 4/A |
| 2026-07-07 | Vera Therapeutics, Inc. | S | 32,550 | $42.07 | 247,944 | Form 4/A |
| 2026-07-07 | Vera Therapeutics, Inc. | S | 2,200 | $43.59 | 151,994 | Form 4 |
| 2026-07-07 | Vera Therapeutics, Inc. | S | 32,550 | $42.07 | 164,694 | Form 4 |
| 2026-07-07 | Vera Therapeutics, Inc. | S | 1,000 | $40.78 | 197,244 | Form 4 |
| 2026-07-07 | Vera Therapeutics, Inc. | S | 10,500 | $42.86 | 154,194 | Form 4 |
| 2026-06-23 | Vera Therapeutics, Inc. | M | 18,500 | $2.9 | 253,744 | Form 4/A |
| 2026-06-23 | Vera Therapeutics, Inc. | S | 88 | $38.43 | 235,244 | Form 4/A |
| 2026-06-23 | Vera Therapeutics, Inc. | S | 18,412 | $37.93 | 235,332 | Form 4/A |
| 2026-05-12 | Vera Therapeutics, Inc. | M | 18,500 | $2.9 | 253,744 | Form 4/A |
| 2026-05-12 | Vera Therapeutics, Inc. | S | 4,281 | $37.09 | 235,244 | Form 4/A |
| 2026-05-12 | Vera Therapeutics, Inc. | S | 14,219 | $36.64 | 239,525 | Form 4/A |
Questions
What stock did Fordyce Marshall buy or sell?
Fordyce Marshall reported 19 non-derivative transactions on 6 SEC ownership filings in Q3 2026: 0 open-market purchases and 14 sales ($6.6M), across 1 company.
Is Fordyce Marshall the same person as other filers with this name?
This page covers SEC CIK 1859453 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/fordyce-marshall-1859453.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.